Neurology

Dr. Juliana Fort is a clinical associate professor at the LSU Health Shreveport Department of Psychiatry and Behavioral Medicine. She serves as the associate director of the Child and Adolescent Psychiatry Fellowship and the director of the psychiatry medical student clerkship. After completing her psychiatric residency and child and adolescent fellowship in the psychiatry department at Tulane Medical School in New Orleans, Louisiana, Dr. Fort graduated from the LSU Health Shreveport School of Medicine. She is a distinguished fellow of the American Psychiatric Association and board certified in geriatric, forensic, addiction, and child and adolescent psychiatry. She is a licensed play therapist and supervisor and has a passion for studying expressive art therapies including drama therapy, improvisation, and mindfulness that enhance psychotherapy, wellness, and personal development.

Dr. Juliana Fort's research interests encompass the integration of expressive art therapies, such as drama therapy, improvisation, and mindfulness, into psychotherapy. She is particularly focused on their applications in child and adolescent psychiatry, as well as their impact on personal development and overall wellness. Additionally, her work spans forensic, addiction, and geriatric psychiatry, with an emphasis on innovative therapeutic approaches that enhance mental health outcomes.

W. S. El Masri is an Hon. Clinical Professor of Spinal Injuries at Keele University and Emeritus Consultant Surgeon at The Robert Jones & Agnes Hunt Orthopaedic Hospital, UK. With extensive training across the UK and the USA, he became a Consultant Surgeon in Spinal Injuries in 1983. He has treated over 10,000 patients with Acute Traumatic Spinal Cord Injuries and pioneered concepts like “Physiological Instability of the Spinal Cord.” A prolific author with over 145 publications, he is a respected figure in spinal injury research and has held prominent positions in international spinal cord societies.

W. S. El Masri's research interests focus on spinal cord injuries, particularly in understanding the biomechanics of spinal instability and the neurological outcomes following injury. He has pioneered concepts such as “Physiological Instability of the Spinal Cord” and “Micro-instability of the injured spine,” and is also dedicated to studying the long-term complications of spinal cord injuries, including bladder cancer and post-traumatic syringomyelia. His work emphasizes the impact of initial injury forces and early management on patient outcomes.

Dr. Jinwei Zhang is a Medicine Professor and Director of the Research Center of Chemical Kinomics at the State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences. He is also a Principal Investigator at the University of Exeter Medical School, UK. His research specializes in ion channels, transporters, and signaling pathways linked to diseases such as stroke and hypertension. Utilizing genetic mouse models, CRISPR/Cas9, and electrophysiology, Dr. Zhang targets ion transporters and kinases to discover new drug targets. He has authored over 100 articles and serves as an editor for multiple scientific journals.

Dr. Jinwei Zhang's research interests focus on the regulation of ion channels, transporters, and signaling pathways in human diseases, particularly stroke and hypertension. He employs advanced techniques like CRISPR/Cas9 gene editing, electrophysiology, and genetic mouse models to explore and target these mechanisms, aiming to discover and validate new drug targets. His work is especially centered on cellular chloride homeostasis and cell volume regulation.

Dr. Virginia Wise Berninger is a Professor Emerita at the University of Washington, where she served on the faculty from 1983 to 2016 in Educational Psychology and Learning Sciences and Human Development. With a Ph.D. in Psychology from Johns Hopkins University, her expertise spans developmental psycholinguistics, cognitive psychology, and neuropsychology. Dr. Berninger has been a Principal Investigator on multiple NIH grants focused on writing disabilities and learning disabilities, including brain imaging and genetics. She continues to publish and present on topics related to educational neuroscience and the brain.

Dr. Virginia Wise Berninger's research interests include the neuropsychology of learning disabilities, particularly writing and reading disabilities, as well as the genetics and brain mechanisms underlying dyslexia. She is focused on translating research findings into educational practices, with a strong emphasis on the development and intervention strategies for typical and atypical learning processes.

Ken Ware is the Founder of Neurotricional Sciences Pty Ltd and NeuroPhysics Therapy and Research. With a career spanning health, wellness, and rehabilitation since 1988, he has presented unique research at over 25 major international science conferences. His work has been published in journals such as *Frontiers in Clinical Physiology* and the *World Journal of Neuroscience*. A former Mr. Universe (1994) and national powerlifting and bodybuilding champion, Ken was awarded the Australian Sports Medal by Queen Elizabeth II in 2000 for his contributions to Australian sports culture.

Ken Ware's research interests include the integration of neurotricional sciences and physics in understanding and enhancing health and rehabilitation. His work focuses on exploring novel therapeutic approaches for neurological and physiological disorders, using interdisciplinary methods that bridge neuroscience, physiology, and biomechanics. His research aims to advance rehabilitation techniques and improve overall wellness through innovative scientific and practical applications.

A board-certified neurologist with fellowships in vascular neurology and neuroimaging, [Name] boasts over 25 years of experience in delivering high-quality healthcare in hospital, ER, and ambulatory settings. They successfully operated a private practice from 1995 to 2022 and have expertise in Botox, Transcranial Magnetic Stimulation, and Laser Photobiomodulation. With a strong interest in clinical research, [Name] is seeking opportunities to contribute to an institution dedicated to excellence in neurological care and research.

research interests include exploring advanced therapeutic techniques such as Botox, Transcranial Magnetic Stimulation, and Laser Photobiomodulation in neurology. They are particularly focused on clinical research aimed at improving treatment outcomes and advancing knowledge in vascular neurology and neuroimaging

Dr. Alain L. Fymat is the President/CEO and Institute Professor at the International Institute of Medicine & Science. Previously, he was the Executive Vice President/COO at the Weil Institute of Critical Care Medicine and has held academic and research positions at various U.S. and European institutions. His career includes roles as Deputy Director of the U.S. Department of Veterans Affairs and Scientific Director at the Loma Linda Veterans Affairs Medical Center. Dr. Fymat's current research focuses on neurodegenerative diseases, oncology, epigenetics, nanomedicine, and emerging infectious diseases. He has published over 575 scientific works and serves as an editor and reviewer for numerous journals and institutions.

Dr. Alain L. Fymat's research interests encompass neurodegenerative diseases (including Alzheimer's and Parkinson's), oncology (particularly glioblastoma), epigenetics, nanomedicine, and emerging infectious diseases. His work explores the interplay between genetic and environmental factors in disease progression and the development of novel therapeutic approaches.

Kenneth B. Storey FRSC is a Canadian scientist and Professor of Biology, Biochemistry, and Chemistry at Carleton University in Ottawa, Canada. His interdisciplinary research spans biochemistry and molecular biology.

Kenneth B. Storey's research focuses on understanding the biochemical and molecular mechanisms underlying stress responses, particularly in relation to metabolism and gene expression. His work aims to elucidate how organisms adapt to environmental challenges and physiological stresses at the molecular level.